Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target‐mediated drug disposition model
- DOI
- 10.1111/bcp.15235
- Published
- 2022-02
- Container
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/bcp.15235,
title = {Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target‐mediated drug disposition model},
author = {Olivier Le Tilly and Philippe Gatault and Christophe Baron and Theodora Bejan‐Angoulvant and Matthias Büchler and Gilles Paintaud and David Ternant},
year = {2022},
journal = {British Journal of Clinical Pharmacology},
doi = {10.1111/bcp.15235},
url = {https://doi.org/10.1111/bcp.15235}
}RIS
TY - JOUR TI - Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target‐mediated drug disposition model AU - Olivier Le Tilly AU - Philippe Gatault AU - Christophe Baron AU - Theodora Bejan‐Angoulvant AU - Matthias Büchler AU - Gilles Paintaud AU - David Ternant PY - 2022 JO - British Journal of Clinical Pharmacology DO - 10.1111/bcp.15235 UR - https://doi.org/10.1111/bcp.15235 ER -
APA
Tilly, O. L., Gatault, P., Baron, C., Bejan‐Angoulvant, T., Büchler, M., Paintaud, G., & Ternant, D. (2022). Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target‐mediated drug disposition model. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15235
Source records
- crossref · retrieved 2026-09-26T15:29:45.542Z